查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825973

2025年产前检测与新生儿筛检全球市场报告

Prenatal Testing & Newborn Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，产前检测和新生儿筛检市场规模迅速扩张，从2024年的62.4亿美元成长到2025年的69.8亿美元，复合年增长率达11.8%。过去的增长得益于基因检测技术的进步、母亲年龄的增长、相关意识和教育的提升以及医疗保健政策法规的完善。

预计未来几年产前检测和新生儿筛检市场规模将快速成长，到2029年将达到109.9亿美元，年复合成长率（CAGR）为12.0%。预测期内的成长归因于遗传咨询、技术进步、就地检验、远端医疗和远端监控。预测期内的主要趋势包括非侵入性产前检测 (NIPT)、胚胎着床前基因检测 (PGT)、远端医疗咨询、母体血液检测、血红蛋白疾病和镰状细胞筛检。

产前检查和新生儿筛检是用于评估妊娠期间胎儿和出生后新生儿健康状况的医疗程序。产前检查包括各种评估，例如血液检查和超音波，以识别胎儿潜在的遗传和发育障碍。新生儿筛检是在出生后不久进行的检测，以检测代谢、遗传和内分泌疾病，以便早期疗育和治疗，从而改善婴儿的健康状况。

产前检测和新生儿筛检的主要诊断类别包括非侵入性方法和侵入性方法。侵入性诊断测试涉及穿透皮肤或身体的程序，包括血液检查、切片检查和结肠镜检查等技术。这些诊断方法利用各种技术，例如筛检和诊断技术，并应用于包括医院和诊断中心在内的各个领域。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，新生儿筛检新生儿筛检新生儿筛检的市场统计数据，包括全球市场规模、区域份额、竞争对手的新生儿筛检新生儿筛检。本产前检测和新生儿筛检市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全面观点。

未来五年12.0%的成长率预测比我们先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国医疗保健体系，因为这会增加从日本和英国进口的串联式质谱质谱仪和代谢紊乱检测试剂的成本，从而可能延误早期疗育，并增加新生儿加护病房的压力。此外，关税的影响也将透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，更为广泛地显现。

产前检测和新生儿筛检市场的成长很大程度上是由婴儿遗传疾病的高发性所驱动的。世界卫生组织已经确定了几种遗传疾病，包括地中海贫血、镰状细胞性贫血、血友病、囊肿纤维化、戴-萨克斯病、X染色体脆折症候群和亨廷顿氏病。镰状性贫血在非洲、美国、古巴、中美洲、沙乌地阿拉伯和印度血统的人群中特别常见。例如，2023 年 2 月，美国研究机构雷迪儿童基因组医学实验室报告称，雷迪儿童医院进行的一项研究发现，41% 的婴儿死亡是由于单元点（孟德尔）遗传疾病造成的。婴儿遗传疾病盛行率的上升正在推动对产前检测和新生儿筛检的需求。

随着出生率的上升，产前检测和新生儿筛检市场有望迎来成长。产前检测评估胎儿出生前的健康状况，而新生儿筛检则可在出生后立即发现某些疾病，以便在必要时进行早期疗育。例如，美国政府机构疾病管制与预防中心 (CDC) 于 2024 年 4 月发布的报告显示，2023 年剖腹产率将连续第四年上升，达到 32.4%。此外，低风险剖腹产率也将上升至 26.6%。因此，出生率的上升是产前检测和新生儿筛检市场的主要驱动力。

产前检测和新生儿筛检市场的主要企业正致力于实施创新项目，利用快速全基因组定序 (rWGS) 技术快速且准确地检测新生儿的遗传疾病，从而实现早期诊断和干预，改善健康状况。与针对特定基因或区域的传统基因检测方法不同，rWGS 可以捕获人体基因组中的所有 DNA，以识别与疾病和病症相关的基因突变。例如，2022 年 6 月，美国雷迪儿童基因组医学研究所启动了 BeginNGS 项目，这是一项旨在在症状出现之前识别和诊断约 400 种已知治疗方法的遗传疾病的创新项目。 BeginNGS 计划优化其基因组序列测定流程，并将其检测能力扩展到约 1000 种疾病。最终目标是每年筛检370 万名新生儿，并使该实践成为全国医院的标准程序。

产前检测和新生儿筛检市场的主要参与企业致力于开发创新的新生儿筛检设备，以增强遗传、代谢和其他健康状况的早期检测，从而实现及时干预并改善新生儿健康状况。新生儿筛检即时检测 (POC) 设备旨在为新生儿提供更快、更便捷、更具成本效益的筛检，并与全球使用的七种标准新生儿筛检测试相容。例如，2023 年 9 月，总部位于印度的 Mylab Discovery Solutions Pvt. Ltd. 推出了新生儿筛检(POC) 设备 MyNeoShield。 MyNeoShield 的设计概念是价格实惠，其成本约为现有解决方案的五分之一。透过直接向医疗保健提供者提供检测，MyNeoShield 旨在改善关键医疗服务的可近性，尤其是服务不足地区的新生儿。

2022年1月，分子诊断公司Exact Sciences Corp.以1.9亿美元收购了Prevention Genetics。此次收购增强了Exact Sciences先进的癌症诊断产品组合，并使其进入遗传性癌症检测(HCT)市场。 Prevention Genetics是一家专门从事产前和新生儿筛检临床DNA（基因）检测的公司，它将补充Exact Sciences的能力并扩大其市场影响力。

产前检测和新生儿筛检市场的主要参与企业包括 PerkinElmer Inc.、Laboratory Corporation of America Holdings (LabCorp)、Natera Inc.、Invitae Corporation、Centogene AG、Cradle Genomics Inc.、Roche Diagnostics International AG、Quest Diagnostics Incorporated、Baebies Inc.、Progenfinity Inc.、Randm. Scientific、Illumina Inc.、Agilent Technologies Inc.、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd.、Bio-Rad Laboratories Inc.、通用电气公司、西门子医疗股份公司、华大基因集团、QIAGEN NV、Veracyte Inc.、NIPD Genetics、Novacyt CompanyA. Diagnostics、Sonic Healthcare Limited、Cepheid a Danaher Company、Guardian Healthcare. Inc. 和泛生子健康（北京）有限公司。

2024年，产前检测和新生儿筛检市场最大的地区是北美。西欧是产前检测和新生儿筛检市场的第二大地区。产前检测和新生儿筛检市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

产前检测和新生儿筛检市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙、加拿大

产前检测和新生儿筛检市场涵盖提供血液检测服务、听力检测服务、CCHD筛检检测和非侵入性检测的营业单位的收益。市场规模包括服务提供者销售或包含在其服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球产前检测与新生儿筛检：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球产前检测与新生儿筛检市场：成长率分析
  • 全球产前检测与新生儿筛检市场表现：规模与成长，2019-2024
  • 全球产前检测与新生儿筛检市场预测：规模与成长，2024-2029年，2034年
  • 全球产前检测与新生儿筛检：总目标市场（TAM）

第六章 市场细分

  • 全球产前检测和新生儿筛检市场（按诊断类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 非侵入性
  • 侵入性
  • 全球产前检测和新生儿筛检市场（按技术、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 筛检技术
  • 诊断技术
  • 全球产前检测和新生儿筛检市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 全球产前检测与新生儿筛检市场：非侵入性细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 血液检测（游离细胞DNA检测）
  • 超音波
  • 母体血清筛检
  • 全球产前检测与新生儿筛检市场：侵入性细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 羊膜穿刺术
  • 绒毛膜绒毛采样（CVS）
  • 脐带穿刺术

第七章 区域和国家分析

  • 全球产前检测与新生儿筛检市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球产前检测与新生儿筛检市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 产前检测与新生儿筛检市场：竞争格局
  • 产前检测与新生儿筛检市场：公司简介
    • PerkinElmer Inc.
    • Laboratory Corporation of America Holdings（LabCorp）
    • Natera Inc.
    • Invitae Corporation
    • Centogene AG

第31章：其他领先和创新企业

  • Cradle Genomics Inc.
  • Roche Diagnostics International AG
  • Quest Diagnostics Incorporated
  • Baebies Inc.
  • Progenity Inc.
  • Ravgen Inc.
  • Strand Life Sciences Pvt. Ltd.
  • Eurofins Scientific
  • Illumina Inc.
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories Inc.
  • General Electric Company
  • Siemens Healthineers AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年产前检测与新生儿筛检市场：提供新机会的国家
  • 2029年产前检测与新生儿筛检市场：细分领域带来新机会
  • 2029年产前检测与新生儿筛检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32735u

Prenatal testing and newborn screening are medical practices designed to evaluate the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing encompasses a range of assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, enabling early intervention and treatment to enhance health outcomes for infants.

The primary diagnostic categories within prenatal testing and newborn screening encompass non-invasive and invasive methods. Invasive diagnostic testing involves procedures that penetrate the skin or body, including techniques such as blood testing, biopsies, and colonoscopies. These diagnostic methods leverage various technologies, including screening and diagnostic technology, and are applied across a range of sectors, including hospitals and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The prenatal testing & newborn screening market research report is one of a series of new reports from The Business Research Company that provides prenatal testing & newborn screening market statistics, including prenatal testing & newborn screening industry global market size, regional shares, competitors with prenatal testing & newborn screening market share, detailed prenatal testing & newborn screening market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal testing and newborn screening tests industry. This prenatal testing and newborn screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal testing & newborn screening market size has grown rapidly in recent years. It will grow from $6.24 billion in 2024 to $6.98 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to advancements in genetic testing, increased maternal age, awareness and education, healthcare policy and regulations.

The prenatal testing & newborn screening market size is expected to see rapid growth in the next few years. It will grow to $10.99 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to genetic counseling, technological advancements, point-of-care testing, telehealth and remote monitoring. Major trends in the forecast period include non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies and sickle cell screening.

The forecast of 12.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. healthcare systems by increasing costs for tandem mass spectrometry equipment and metabolic disorder assays imported from Japan and the UK, potentially delaying early interventions and raising neonatal Intensive Care Unit burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the prenatal testing and newborn screening market is significantly driven by the high prevalence of genetic diseases in infants. The World Health Organization identifies genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington's disease. Among these, Sickle Cell Anemia, which predominantly affects individuals with African, American, Cuban, Central American, Saudi Arabian, and Indian ancestry, is particularly widespread. For instance, in February 2023, the Rady Children's Institute for Genomic Medicine, a U.S.-based research institute, reported that a study conducted at Rady Children's Hospital found that 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. This heightened prevalence of genetic diseases in infants has driven the demand for prenatal testing and newborn screening.

The prenatal testing and newborn screening market is poised for growth due to an increase in birth rates. Prenatal testing assesses the health of fetuses before birth, while newborn screening detects specific medical conditions shortly after birth, enabling early intervention when necessary. For example, in April 2024, a report published by the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, revealed that the cesarean delivery rate increased for the fourth consecutive year in 2023, reaching 32.4%. Additionally, the rate of low-risk cesarean deliveries rose to 26.6%. Therefore, the rising birth rate is a key driver of the prenatal testing and newborn screening market.

Leading companies in the prenatal testing and newborn screening market are focusing on introducing innovative programs that leverage rapid Whole Genome Sequencing (rWGS) technology to quickly and accurately detect genetic disorders in newborns, allowing for early diagnosis and intervention to improve health outcomes. rWGS technology is an advanced genomic technique that rapidly sequences an individual's entire genome. Unlike traditional genetic testing methods that target specific genes or regions, rWGS captures all the DNA in a person's genome to identify genetic variants associated with diseases or disorders. For example, in June 2022, Rady Children's Institute for Genomic Medicine, a U.S.-based organization, launched BeginNGS, a novel program aimed at identifying and diagnosing approximately 400 genetic disorders with known treatment options before symptoms appear. BeginNGS is optimizing genomic sequencing processes and plans to expand testing capabilities to include around 1,000 disorders. The ultimate goal is to screen 3.7 million newborns annually, making this practice a standard procedure in hospitals nationwide.

Key players in the prenatal testing and newborn screening market are focused on developing innovative newborn screening devices to enhance the early detection of genetic, metabolic, and other health conditions, enabling timely interventions and improved health outcomes for newborns. Newborn screening point-of-care devices are designed to provide faster, more accessible, and cost-effective screening for newborns, accommodating the seven standard newborn screening tests conducted globally. For example, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is designed to be low-cost, priced at about one-fifth of existing solutions, which typically range from ₹50 lakhs to ₹7 crores. By bringing testing directly to healthcare providers, MyNeoShield aims to improve access to critical health services for newborns, particularly in underserved regions.

In January 2022, Exact Sciences Corp., a molecular diagnostics company, completed the acquisition of Prevention Genetics for $190 million. This acquisition enhances Exact Sciences' advanced cancer diagnostics portfolio and allows the company to enter the hereditary cancer testing (HCT) market. Prevention Genetics, a company specializing in clinical DNA (genetic) tests for prenatal testing and newborn screening, complements Exact Sciences' capabilities and expands its market presence.

Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal testing & newborn screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The prenatal testing & newborn screening market includes revenues earned by entities by providing blood test services, hearing test services, CCHD screening tests, and non-invasive tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal Testing & Newborn Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal testing & newborn screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal testing & newborn screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prenatal testing & newborn screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Type: Non-Invasive; Invasive
  • 2) By Technology: Screening Technology; Diagnostic Technology
  • 3) By End user: Hospitals; Diagnostic centers
  • Subsegments:
  • 1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening
  • 2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis
  • Companies Mentioned: PerkinElmer Inc.; Laboratory Corporation of America Holdings (LabCorp); Natera Inc.; Invitae Corporation; Centogene AG; Cradle Genomics Inc.; Roche Diagnostics International AG; Quest Diagnostics Incorporated; Baebies Inc.; Progenity Inc.; Ravgen Inc.; Strand Life Sciences Pvt. Ltd.; Eurofins Scientific; Illumina Inc.; Agilent Technologies Inc.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories Inc.; General Electric Company; Siemens Healthineers AG; BGI Group; QIAGEN N.V.; Veracyte Inc.; NIPD Genetics; Novacyt UK; Ariosa Diagnostics Inc.; Verinata Health Inc.; Counsyl a Myriad Company; GenPath Diagnostics; Sonic Healthcare Limited; Cepheid a Danaher Company; Guardant Health Inc.; Genetron Health (Beijing) Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal Testing & Newborn Screening Market Characteristics

3. Prenatal Testing & Newborn Screening Market Trends And Strategies

4. Prenatal Testing & Newborn Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Prenatal Testing & Newborn Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Prenatal Testing & Newborn Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Prenatal Testing & Newborn Screening Market Growth Rate Analysis
  • 5.4. Global Prenatal Testing & Newborn Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Prenatal Testing & Newborn Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Prenatal Testing & Newborn Screening Total Addressable Market (TAM)

6. Prenatal Testing & Newborn Screening Market Segmentation

  • 6.1. Global Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive
  • Invasive
  • 6.2. Global Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening Technology
  • Diagnostic Technology
  • 6.3. Global Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic centers
  • 6.4. Global Prenatal Testing & Newborn Screening Market, Sub-Segmentation Of Non-Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests (C ell-Free DNA Testing)
  • Ultrasound
  • Maternal Serum Screening
  • 6.5. Global Prenatal Testing & Newborn Screening Market, Sub-Segmentation Of Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amniocentesis
  • Chorionic Villus Sampling (CVS)
  • Cordocentesis

7. Prenatal Testing & Newborn Screening Market Regional And Country Analysis

  • 7.1. Global Prenatal Testing & Newborn Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Prenatal Testing & Newborn Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal Testing & Newborn Screening Market

  • 8.1. Asia-Pacific Prenatal Testing & Newborn Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal Testing & Newborn Screening Market

  • 9.1. China Prenatal Testing & Newborn Screening Market Overview
  • 9.2. China Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal Testing & Newborn Screening Market

  • 10.1. India Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal Testing & Newborn Screening Market

  • 11.1. Japan Prenatal Testing & Newborn Screening Market Overview
  • 11.2. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal Testing & Newborn Screening Market

  • 12.1. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal Testing & Newborn Screening Market

  • 13.1. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal Testing & Newborn Screening Market

  • 14.1. South Korea Prenatal Testing & Newborn Screening Market Overview
  • 14.2. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal Testing & Newborn Screening Market

  • 15.1. Western Europe Prenatal Testing & Newborn Screening Market Overview
  • 15.2. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal Testing & Newborn Screening Market

  • 16.1. UK Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal Testing & Newborn Screening Market

  • 17.1. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal Testing & Newborn Screening Market

  • 18.1. France Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal Testing & Newborn Screening Market

  • 19.1. Italy Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal Testing & Newborn Screening Market

  • 20.1. Spain Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal Testing & Newborn Screening Market

  • 21.1. Eastern Europe Prenatal Testing & Newborn Screening Market Overview
  • 21.2. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal Testing & Newborn Screening Market

  • 22.1. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal Testing & Newborn Screening Market

  • 23.1. North America Prenatal Testing & Newborn Screening Market Overview
  • 23.2. North America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal Testing & Newborn Screening Market

  • 24.1. USA Prenatal Testing & Newborn Screening Market Overview
  • 24.2. USA Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal Testing & Newborn Screening Market

  • 25.1. Canada Prenatal Testing & Newborn Screening Market Overview
  • 25.2. Canada Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal Testing & Newborn Screening Market

  • 26.1. South America Prenatal Testing & Newborn Screening Market Overview
  • 26.2. South America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal Testing & Newborn Screening Market

  • 27.1. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal Testing & Newborn Screening Market

  • 28.1. Middle East Prenatal Testing & Newborn Screening Market Overview
  • 28.2. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal Testing & Newborn Screening Market

  • 29.1. Africa Prenatal Testing & Newborn Screening Market Overview
  • 29.2. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal Testing & Newborn Screening Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal Testing & Newborn Screening Market Competitive Landscape
  • 30.2. Prenatal Testing & Newborn Screening Market Company Profiles
    • 30.2.1. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Centogene AG Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal Testing & Newborn Screening Market Other Major And Innovative Companies

  • 31.1. Cradle Genomics Inc.
  • 31.2. Roche Diagnostics International AG
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Baebies Inc.
  • 31.5. Progenity Inc.
  • 31.6. Ravgen Inc.
  • 31.7. Strand Life Sciences Pvt. Ltd.
  • 31.8. Eurofins Scientific
  • 31.9. Illumina Inc.
  • 31.10. Agilent Technologies Inc.
  • 31.11. Thermo Fisher Scientific Inc.
  • 31.12. F. Hoffmann-La Roche Ltd.
  • 31.13. Bio-Rad Laboratories Inc.
  • 31.14. General Electric Company
  • 31.15. Siemens Healthineers AG

32. Global Prenatal Testing & Newborn Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal Testing & Newborn Screening Market

34. Recent Developments In The Prenatal Testing & Newborn Screening Market

35. Prenatal Testing & Newborn Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Prenatal Testing & Newborn Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Prenatal Testing & Newborn Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Prenatal Testing & Newborn Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer